Bornert O, Hogervorst M, Nauroy P, Bischof J, et al. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study. J Invest Dermatol 2021;141:883-893.
PMID: 32946877